355 related articles for article (PubMed ID: 8816801)
1. Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.
Stryhn A; Andersen PS; Pedersen LO; Svejgaard A; Holm A; Thorpe CJ; Fugger L; Buus S; Engberg J
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10338-42. PubMed ID: 8816801
[TBL] [Abstract][Full Text] [Related]
2. Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. II. Cross-reaction between a monoclonal antibody and two alpha beta T cell receptors.
Rognan D; Engberg J; Stryhn A; Andersen PS; Buus S
J Comput Aided Mol Des; 2000 Jan; 14(1):71-82. PubMed ID: 10702926
[TBL] [Abstract][Full Text] [Related]
3. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
Kievits F; Wijffels J; Lokhorst W; Ivanyi P
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
[TBL] [Abstract][Full Text] [Related]
4. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
5. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries.
Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
J Exp Med; 1995 Jun; 181(6):2097-108. PubMed ID: 7539039
[TBL] [Abstract][Full Text] [Related]
6. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
Calin-Laurens V; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
Vaccine; 1993; 11(9):974-8. PubMed ID: 7692684
[TBL] [Abstract][Full Text] [Related]
7. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.
Yanagi Y; Tishon A; Lewicki H; Cubitt BA; Oldstone MB
J Virol; 1992 Apr; 66(4):2527-31. PubMed ID: 1372370
[TBL] [Abstract][Full Text] [Related]
8. Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.
Fan S; Wu Y; Wang S; Wang Z; Jiang B; Liu Y; Liang R; Zhou W; Zhang N; Xia C
J Virol; 2016 Aug; 90(15):6625-6641. PubMed ID: 27170754
[TBL] [Abstract][Full Text] [Related]
9. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
10. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
11. Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.
Cao W; Myers-Powell BA; Braciale TJ
J Exp Med; 1994 Jan; 179(1):195-202. PubMed ID: 7505798
[TBL] [Abstract][Full Text] [Related]
12. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
Lobigs M; Müllbacher A
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
[TBL] [Abstract][Full Text] [Related]
13. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
14. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.
Reiter Y; Di Carlo A; Fugger L; Engberg J; Pastan I
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4631-6. PubMed ID: 9114042
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
17. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
18. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
[TBL] [Abstract][Full Text] [Related]
19. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
[TBL] [Abstract][Full Text] [Related]
20. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
